Despite ongoing efforts to establish in vitro testing strategies, in vivo animal tests are still used to assess the sensitizing potential of chemicals leading to allergic contact dermatitis. Most in vitro attempts have explored whether phenotypic or functional changes of antigen-presenting cells can serve as a surrogate for in vivo hazard identification. Dendritic-like cells cultivated from bone marrow, cord blood CD34 ϩ progenitor cells, or CD14
ϩ peripheral monocytes are used instead of antigen-presenting cells of the skin (Langerhans cells), which are difficult to isolate in sufficient numbers.
Different markers of dendritic cell (DC) 3 maturation have been found to indicate the process of sensitization by contact allergens. Aiba et al. (1 ) reported that sensitizers increase the expression of HLA-DR, CD54, and CD86 on monocyte-derived DCs (Mo-DCs). Likewise, Coutant et al. (2 ) found augmented expression of HLA-DR, CD54, CD40, and CD86. In studies by our group (3) (4) (5) , we observed CD86 as the most reliable marker for sensitizers, but it nevertheless depended on interdonor variation.
Besides the differential expression of surface molecules, the production of specific cytokines has been related to the maturation process of immature DCs (iDCs). The contact sensitizers 2,4,6-trinitrobenzenesulfonic acid (TNBS), 2,4-dinitrofluorobenzene (DNFB), NiSO 4 , and K 2 Cr 2 O 7 induced upregulation of IL-1␤ mRNA in Mo-DCs (6 ). Pichowski (7 ) confirmed this effect using strong sensitizers, but also found that the upregulation was donor dependent. In further gene expression studies in Mo-DCs, cells were exposed to the allergen dinitrobenzene sulfonic acid (DNBS), and gene expression was analyzed with an Affymetrix U95Av2 Gene Chip (8 ).
Verheyen et al. (9 ) observed upregulation of mRNA in CD34-derived DCs for IL1␤, IL6, IL8, CCL2, CCL3, CCL4, and CCL3L1 by sensitizers. Investigations on the secretion of cytokines by Mo-DCs demonstrated the induction of IL8 as a parameter identifying contact allergens (10 ) .
In the present work, we used a targeted microarray to show the principal functionality of a microarraybased test system to study the allergen-induced maturation process of Mo-DCs and to discriminate between contact sensitizers and irritants. We primarily selected genes that had already been shown to be involved in DC maturation or antigen-presenting processes. Furthermore, to produce a microarray suitable for toxicological studies, we included in the chip design several genes that had been used in immunotoxicological testing strategies in our laboratory (Supplemental Data  Table 1 ) (see, e.g., (10, 4 -18 ) ).
iDCs cultured from monocytes from different human blood donors were treated with 2 known contact sensitizers, NiSO 4 and Bandrowski's base (BB), and the irritant SDS. Using flow cytometry and the immune toxicity chip, we compared gene expression in these cells to gene expression in solvent-treated cells. We identified several immune-relevant genes that were differentially expressed after allergen treatment but not after application of SDS. Real-time PCR was used to confirm the results for 9 of those genes.
Materials and Methods

DESIGN AND PRODUCTION OF THE IMMUNE TOXICITY CHIP
Sixty-six immune-relevant genes, 7 housekeeping genes, and 8 negative controls and external spike controls (see Supplemental Table 1 in the Data Supplement that accompanies the online version of this article at http://www.clinchem.org/content/vol54/issue3) were spotted on ARChip Epoxy glass slides (Austrian Research Centers GmbH, ARC) using an Omnigrid Arrayer (GeneMachines). Gene-specific (5Ј amino-modified) oligonucleotide probes were spotted in 100 mmol/L sodium phosphate buffer, 0.01% SDS (final probe concentration 10 mol/L). Using the OligoCalc program (19 ), we designed gene-specific DNA of an average length of 50 nucleotides optimized to a melting temperature of 73°C. Of each probe, 4 replicates were printed. The immune toxicity chip consists of genes expected to be differentially regulated when analyzing gene expression of exposed immune cells. Consequently global normalization cannot be employed. We therefore included calibration controls and ratio controls of the Lucidea Universal Score Card System (GE Healthcare) in the chip design. RNA samples hybridized to the immune toxicity chip included Score Card spike mixes according to the Lucidea Score Card User's guide. The control spots are designed to generate predetermined fold changes. All calibration controls have a theoretical fold change of 1 at decreasing intensities and can be used for normalization.
CULTURE OF IDCS AND CHEMICAL EXPOSURE
We generated iDCs as described (3 ) . We added 400 kU/L interleukin (IL)-4 and 1000 kU/L granulocytemacrophage colony-stimulating factor (GM-CSF) (Strathman Biotech) to the incubation medium, and medium was refreshed every second day.
On day 6, iDCs were treated with NiSO 4 (Merck), BB (ICN Biomedicals Inc.), or SDS (Merck) and the corresponding solvent for 24 h. We applied different concentrations of each chemical to establish nontoxic concentrations (90% viability) for further experiments (Fig. 1) . NiSO 4 and SDS were dissolved in water, and BB was dissolved in DMSO (Merck) to a final DMSO concentration of 1 g/L. DCs derived from 3 to 4 donors were used for each chemical.
FLOW CYTOMETRIC ANALYSIS
Cells were harvested and 300 L of the culture was diluted in 2 mL PBS, 5 g/L BSA, and centrifuged (10 min, 300g). We incubated the cell pellets with 10 L monoclonal antibody for 30 min using the following antibodies: fluorescein isothiocyanate (FITC) antihuman CD1a, phycoerythrin (PE) antihuman CD86, and anti-HLA-DR FITC (BD Pharmingen). After incubation, cells were washed again and finally diluted in 0.5 mL PBS. We performed flow cytometric analysis on a Coulter Epics XL-MCL (Beckman Coulter Inc.) with EXPO32™ ADC XL 3 Color v1.1C, Expo32 v1.2 Analysis v1.1C (Beckman Coulter Inc.). DCs were defined by light scatter, dead cells were gated out, and fluorescence histograms were evaluated after the method of Overton (20 ) .
To determine cytotoxicity, we performed staining with propidium iodide (PI) (Sigma-Aldrich). We incubated 500 L of the culture with 10 L PI (0.2 g/L in PBS) for 5 min at 4°C and measured the percentage of PI-positive cells by use of flow cytometry. Viability was expressed as 100% -cytotoxicity (%).
RNA EXTRACTION
Cells were harvested by centrifugation (10 min, 300g, 4°C), and cell pellets were resuspended in Trizol (Invitrogen). We isolated total RNA using Trizol as described by the manufacturer followed by an RNeasy minicolumn cleanup (Qiagen). RNA pellets were resuspended in 100 L RNase-free water, and 350 L buffer RLT (Qiagen) and 250 L ethanol were added.
We applied samples to RNeasy minicolumns and performed RNA cleanup according to the manufacturer's protocol. RNA was eluted with 3ϫ 30 L of RNase-free water.
LABELING AND HYBRIDIZATION
We analyzed RNA expression levels from chemicaltreated DCs and from DCs exposed to solvent control on 1 microarray using the 3DNA Array 350-kit (Genisphere) as described by the manufacturer. For each RNA, we performed 2 technical replicates (dye swaps).
Before hybridization, the chip surface was blocked using 50 mmol/L ethanolamine, 0.2 mol/L Tris, pH 9, and 1 g/L SDS for 30 min. After washing the slides in 4ϫ SSC and 1 g/L SDS, the chips were blow-dried and ready for hybridization.
Only 2 g of total RNA was reverse-transcribed using dt primer from the kit, which incorporates a capture sequence at the 5Ј end of the cDNA. The unlabeled cDNA was hybridized to the array overnight at 60°C using vial 12 hybridization buffer (3DNA Array 350-kit). Subsequently, hybridized cDNA was detected using fluorescently labeled 3DNA dendrimer molecules (3DNA Array 350-kit) with a sequence complementary to the capture sequence of the cDNA. The dendrimer molecules were incubated on the array for 4 h at 60°C using vial 6 hybridization buffer (3DNA Array 350-kit). Every dendrimer contains on average 375 fluorescent dyes, resulting in a strong signal enhancement.
DATA ANALYSIS
We scanned the slides by use of a GenePix 4000A scanner (Molecular Devices) with adjusted settings (equal for both wavelengths) avoiding saturated signals. Raw image data were extracted using GenePix 3.0 software (Molecular Devices).
We performed data analysis with the software package Limma for the R computing environment (21 ) . Limma is part of the Bioconductor project at http://www.bioconductor.org (22 ) .
For every hybridization, background intensities were subtracted from the foreground intensities for each spot. Data were normalized with the Lucidea Universal Score Card System using a Loess procedure (21 ) .
For statistical analysis, a linear model was fitted, and the empirical Bayes method (23 ) was applied. Within-array replicates were integrated in the analysis as described (24 ) . We specified technical replicates (dye swaps) and biological replicates (experiments employing DCs from different blood donors) for each chemical.
We ranked the significance of the differentially expressed genes using the B statistic (23 ), and we made lists of the top-regulated genes considering the follow- ing criteria: fold induction Ն1.5 or Յ0.6 and B statistic Ն0.
REAL-TIME PCR
Quantitative real-time PCR was performed using TaqMan Gene Expression Assays (Applied Biosystems) with RNA isolated from 3 of 4 DC cultures treated with SDS or NiSO 4 for 24 h (Table 1) .
For 30 L cDNA, 210 ng RNA was reverse-transcribed using Superscript™ II Transcriptase (Invitrogen) according to the manufacturer's instructions. Real-time PCR was carried out on an ABI 5700 Sequence Detection System using GeneAmp5700SDS software. PCR was performed in a 20-L reaction volume containing 0.5 L cDNA using the TaqMan Universal PCR Master Mix with AmpErase UNG (Applied Biosystems) as described by the manufacturer. In triplicates, each sample was normalized to 2 housekeeping genes (RPLPO, PPIA) 4 and biological replicates were analyzed using the 2 -⌬⌬C T method (25 ) . All resulting fold inductions were log 2 -transformed, and subsequent analysis was performed with the transformed data. We performed a 1-sample t test to analyze whether fold inductions were significantly different from 0 (P Յ 0.05).
Results
DOSE-RESPONSE EXPERIMENTS
PI staining of DCs exposed to increasing chemical concentrations revealed a decrease in viability for NiSO 4 and SDS-treated cells, whereas different concentrations of BB had only minor effects. For further experiments, we chose concentrations resulting in Ն90% viability (300 mol/L NiSO 4 , 3 mg/L BB, 10 mg/L SDS). CD86 expression increased with higher concentrations of all chemicals, indicating unspecific upregulation in treated cells, if cytotoxic concentrations are employed (Fig. 1) .
FLOW CYTOMETRIC ANALYSIS OF DCS BEFORE AND AFTER
EXPOSURE
Before exposure, we analyzed expression of the DC marker CD1a using flow cytometry, and Ͼ90% of the cells were found to be highly positive (data not shown).
After the treatment, we analyzed the effects of chemicals on the expression of 2 maturation markers, CD86 and HLA-DR. We defined the percentage of cells positive for CD86 and HLA-DR by use of the Overton method (Fig. 2) and calculated mean values from all donors.
In microarray experiments analyzing iDCs exposed to NiSO 4 for 1, 3, and 5 h and to BB for 4 h, fewer genes were found to be differentially expressed than in cells treated for 24 h (data not shown). Flow cytometric analysis of allergen-treated DCs after 48 h did not show a significant increase of maturation markers compared with 24 h (earlier experiments, data not published). Therefore, iDCs were exposed for 24 h in all experiments.
MICROARRAY ANALYSIS AND REAL-TIME PCR
The sensitizer NiSO 4 induced the most prominent augmentation of CD86 and HLA-DR expression in iDCs. Flow cytometry and calculation of the percentage of cells positive for the 2 markers using histogram subtraction showed that on average 80% of the culture expressed CD86 and HLA-DR, compared with the solvent control (Fig. 3) . Therefore, NiSO 4 clearly induced maturation of the cells. Microarray analysis of the NiSO 4 -treated cells also indicated strong effects of the sensitizer. Using our criteria (fold induction Ն1.5 or Յ0.6 and B statistic Ն0), 21 genes were found to be differentially expressed compared to solvent control (see Supplemental Table 1 in the online Data Supplement). 4 Human genes: RPLP0, ribosomal protein, large, P0; PPIA, peptidylprolyl isomerase A (cyclophilin A); TNFRSF1A, tumor necrosis factor receptor superfamily, member 1A; CCL11, CCL17, CCL19, CCL22, CCL3, CCL4, chemokine (C-C motif) ligand 11, 17, 19, 22, 3, and 4; CL5 chemokine (C-C motif) ligand 5; CCR1, CCR7, CCR8, chemokine (C-C motif) receptor 1, 7, and 8; CD86, CD86 molecule; CXCL12, chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1); CXCL2, chemokine (C-X-C motif) ligand 2; CXCR4, chemokine (C-X-C motif) receptor 4; IL12B, interleukin 12B (natural killer cell-stimulating factor 2, cytotoxic lymphocyte maturation factor 2, p40); IL15, IL4, IL8, interleukin-15, Ϫ4, and Ϫ8; PGK1, phosphoglycerate kinase 1. Genes were randomly selected from genes identified as differentially expressed with the immune toxicity chip after exposure to one or both sensitizers (CCL17, CCR7, CXCR4, IL8, TNFRSF1A). TaqMan gene expression assays were used (assay ID).
To confirm our microarray results, we analyzed changes in expression of 9 genes by use of real-time PCR (Table 1 ). The same RNA that was already used for the microarray experiments was used for the PCRs. Fig. 4a shows the fold inductions of the selected genes analyzed with real-time PCR and the microarray results described in Supplemental Table 1 in the online Data Supplement. Except for CCL17 and IL12B p40, all fold inductions measured with real-time PCR were significantly different from 0. Although fold inductions of NiSO 4 -treated cells detected by PCR analysis were considerably higher than those measured by microarray analysis, upregulation of all but 1 gene could be confirmed. TNFRSF1A was found to be upregulated with microarray analysis, whereas real-time PCR results indicated its downregulation (Fig. 4a) .
The effect of BB on iDCs was lower than the effect of NiSO 4 : 56% of the cells were CD86 ϩ and 45% were HLA-DR ϩ (Fig. 3) . Therefore, BB could induce maturation of approximately half the cells. In accordance with flow cytometry, induction of gene expression with BB was lower than with NiSO 4 , as shown by microarray analysis. Compared with solvent control, 10 genes were found to be differentially expressed (see Supplemental Table 1 in the online Data Supplement). For 5 of these genes (IL8, CCL17, CXCR4, TNFRSF1A, and CCR7), we analyzed specificity of the probes with real-time PCR, which confirmed the specificity of the probes for all but 1 gene (TNFRSF1A).
Comparing the gene expression patterns induced by NiSO 4 and BB, we found 8 genes that were differentially expressed in both groups (see the bold data in Supplemental Table 1 in the online Data Supplement). These genes are potential markers for the identification of contact sensitizers.
After exposure of iDCs to SDS, expression of CD86 and HLA-DR was upregulated in only 24% and 23% of the cells, respectively (Fig. 3) . Using our criteria, no differentially expressed genes were detected with the immune toxicity chip. We noticed that 27 genes showed weak but significant (B Ͼ 0) upregulation of gene expression (see Supplemental Table 1 in the online Data Supplement), but all fold inductions were Ͻ1.5.
Real-time PCR was performed for the same genes as for NiSO 4 -exposed cells and showed no significant induction of gene expression, confirming the microarray results (Fig. 4b) .
Discussion
The analysis of chemical-treated DCs revealed clear differences of gene expression patterns between cells treated with sensitizers (NiSO 4 , BB) and cells treated with an irritant (SDS). Although a significant increase in RNA levels was observed for several genes after application of SDS, none of the investigated genes had a fold induction Ն1.5.
In contrast, application of sensitizing chemicals resulted in significant upregulation of the expression of 21 (NiSO 4 ) or 10 (BB) genes with a fold induction Ն1.5. The genes detected after both NiSO 4 and BB treatment (IL8, CCL17, TNFRSF1A, CCR7, CCL22, CD86, CXCR4, and PPIA) might be candidates for a general identification of sensitizing chemicals. Therefore, based on our first results, we propose that the discrimination of irritants and sensitizers might be possible using our assay.
Nine genes were analyzed with real-time PCR, and the microarray results could be confirmed for all genes except TNFRSF1A, proving the high reliability of our microarray assay. Differences in TNFRSF1A expression might be explained by an unspecific microarray probe not detected during original probe design. Reanalysis of the PCR assay and the microarray probe on the CGAP Unigene BLAST tool (http://cgap.nci.nih. gov/Genes/SeqFinder) revealed unspecific binding of the probe with CDNA FLJ27297 fis, clone TMS04309, highly similar to TNFRSF1A at e ϭ 0.0001, while the PCR assay was specific for this gene. Therefore, a probe redesign should be performed for TNFRSF1A.
Analyzing gene expression after NiSO 4 exposure, 7 genes (CCR7, CXCL2, CXCR4, IL15, IL8, PGK1, and TNFRSF1A) showed fold inductions significantly different from 0 using real-time PCR. In general, fold inductions measured with PCR were higher than those measured with microarray analysis. This was also stated by Tureci et al. (11 ) .
The present study used iDCs, which are known to mature and migrate to the draining lymph nodes after contact with sensitizers. This process is controlled by a rapid and coordinated regulation of chemokines and chemokine receptors. In this investigation, gene expression of the chemokine receptors CCR7 and CXCR4 was upregulated after application of both sensitizers. In addition, more mRNA for CCR8 could be detected after application of NiSO 4 , whereas CCR1 expression was downregulated.
The upregulation of CCR7 upon maturation of DCs was shown in 1998 (12 ) . The same study reported the induction of directional migration of mature DCs by the CCR7-ligand CCL19, indicating involvement of CCR7 in the induction phase of delayed-type hypersensitivity response. The expression of CCR7 along with the maturation of DCs and their responsiveness to CCL19 was also published by Dieu et al. (13 ) . Apart from its function in chemotaxis, CCR7 was shown to regulate the cyto-architecture of DCs (26 ) . CCR7-deficient mice lack contact sensitivity and delayed-type hypersensitivity reactions, and their mature skin DCs fail to migrate into the draining lymph nodes (27 ) . CCR8 was shown to be expressed on T cells (28 ) . CCR8 ϩ T cells are abundant in the skin and rare or absent in peripheral blood, indicating a role in skinhoming of T cells (29 ) . However, Mo-DCs also express CCR8, indicating-like CCR7-its role in DC migration from skin to the lymph node (14 ) . CXCR4, the membrane receptor for CXCL12, has been shown to play an important role during constitutive basal trafficking of leukocytes (30 ) , and might also contribute to assemble DCs in the lymph nodes (11 ) .
Upregulation of CCR7 and CXCR4 was also found by others. Schoeters and colleagues (31, 32 ) reported on an upregulation of CCR7 after treatment of CD34 ϩ DCs with several allergens, and this effect was confirmed by Tureci et al. (11 ) after treatment of Mo-DCs with CD40L.
One group reported the reduction of CXCR4 protein amounts in a fetal skin-derived cell line after treatment with contact sensitizers (33 ) . These results contradict other studies employing Mo-DCs (11, 15 ) and our own results, where expression of CXCR4 is upregulated upon allergen treatment.
We further found that several chemokines (IL8, CCL17, and CCL22) known to be involved in allergy were upregulated after exposure of iDCs to both sensitizers. NiSO 4 also induced expression of CCL11, CCL5, CCL3, and CXCL2, and BB exposure resulted in upregulation of CCL4.
CCL22 and CCL17 are the most abundant chemokines produced by DCs (34 ) . CCL22 is constitutively expressed in iDCs (35 ) , and the upregulation of gene or protein expression during maturation was shown by several groups (16, 17 ) . Its receptor (CCR4) is expressed by recently activated T cells, showing the importance of CCL22 in regulation of DC-T cell contact. Moreover, DCs positive for CCL22 were detected in allergic contact dermatitis in the epidermis and the dermis. The CCL22-positive DCs were mainly mature CD83 ϩ cells. In normal skin, no CCL22 expression was found.
CCL17 is expressed in keratinocytes (36 ) and DCs (16 ) . As a ligand for CCR4 and CCR8, which are expressed by T cells, it might also be involved in the specific interaction of DCs with T cells.
In humans, CCL17 is upregulated in Mo-DC after lipopolysaccharide (LPS) stimulation, and Hashimoto et al. (16 ) showed the upregulation of CCL17 in mature DCs.
CCL17 and CCL5 were shown to be involved in a mouse model of allergic contact dermatitis (37 ) . In our study, CCL5 was upregulated after NiSO 4 treatment. Toebak et al. (10 ) found higher amounts of CCL17 protein only after application of LPS, NiSO 4 , and CrCl 3 to iDCs, whereas other sensitizers did not result in significant upregulation. In their study, IL8 was the only chemokine significantly upregulated at the protein level in response to all sensitizers analyzed. They proposed a role for IL8 in the onset of Langerhans cell migration in the skin. Moreover, neutrophils induced by IL8 release chemotactic mediators, which attract T cells. Therefore, IL8 might play a role in T cell accumulation via neutrophil attraction.
In our study, the expression of 2 additional cytokines (IL12B, IL15) was upregulated in NiSO 4 treated DCs. DC-derived IL15 is required for the functional maturation of DCs (38 ) .
IL12 is required for Th1 cell development, acting in an antagonistic equilibrium with IL4, which favors differentiation of Th2 cells (18 ) . The heterodimeric cytokine is composed of a heavy chain (40 kDa) and a light chain (35 kDa). Both gene products are necessary for the biologically active cytokine; however, transcripts for the light chain were detected in many cell types in low abundance, whereas transcripts for the heavy chain were found only in cells producing biologically active IL12, and their expression was highly regulated (39 ) . Therefore, the upregulation of the p40 gene is a better indicator for the production of active IL12 and it is more easily detected. In line with these facts, only IL12Bp40 was upregulated in our experiments with NiSO 4. Some housekeeping genes were detected as slightly upregulated with the microarray after exposure of iDCs to NiSO 4 (PPIA, HPRT, PGK1) or BB (PPIA). Several studies showed changes in expression of housekeeping genes under certain conditions (40 ) . Therefore, the maturation process of DCs, accompanied by changes in morphology and function, might lead to changes in expression of genes involved in basic processes in the cell. Since all chemicals were applied in concentrations resulting in similar cytotoxicity (Fig. 1) , general cytotoxicity can be excluded as reason for the upregulation of these genes.
The microarray assay proved to be very useful to elicit changes in expression of immune-relevant genes after treatment of iDCs with chemical sensitizers and irritants. We will analyze more chemicals to decide whether the currently selected candidate genes are generally able to discriminate between contact sensitizers and irritants. The small-sized panel of probes allows rapid analysis of the results. Our test system could establish a reliable in vitro assay, reducing the number of laboratory animals needed for such testing and offering the advantage of testing using a human system. 
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